Fairvalue-Calculator Fairvalue-Calculator
EN DE

Anhui Huangshan Capsule Co (002817) Fair Value & Analysis

Healthcare · CN · Market cap 1.9B CNY

Price¥6.28
Fair Value¥3.69
Upside-41.2%
Quality93/100
Evidence: High Range ¥2.77 – ¥4.62

Fair value as of: Jun 25, 2026

Analysis

Anhui Huangshan Capsule Co (002817) currently trades at ¥6.28, while our model-based Fair Value estimate is ¥3.69 — implying the stock looks roughly 41.2% overvalued today. We read business quality at 93/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. The company offers pullulan capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose hollow capsules, and hydroxypropyl starch hollow capsules. The company was founded in 1989 and is headquartered in Xuancheng, China.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +885% Jiangsu Hengrui Pharmaceuticals Co (600276) -44% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -75% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -78%

Frequently asked questions

Is Anhui Huangshan Capsule Co (002817) undervalued?
As of Jun 25, 2026, our model estimates a fair value of ¥3.69 versus a price of ¥6.28 — about −41% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 002817?
Our 21-model fair value for Anhui Huangshan Capsule Co is ¥3.69 (as of Jun 25, 2026), built from audited fundamentals. The current price is ¥6.28.
What is the quality score of 002817?
Anhui Huangshan Capsule Co has a Quality Score of 93/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.